The modified membrane was used to immobilize a polyclonal antibody for the prostate-specific antigen (PSA), and the resulting immunosensing interface was deposited on the surface of Ag/AgCl electrode for the label-free potentiometric determination of the cancer biomarker. The gene discussed is KLK3; the disease is cancer.